Archive for July, 2015

« Previous Entries

Standing better for heart health than sitting

Friday, July 31st, 2015

According to a new study from Australia, standing may be better for heart health than sitting. The study looked at how standing, stepping and sitting impacts heart health, fitness and weight. The study found that only two hours of standing rather than sitting may decrease levels of blood fat and blood sugar. Lead author Genevieve […]

High-salt diets raise hypertension risk

Thursday, July 30th, 2015

A new Japanese study has found that a high-salt diet can increase the risk of hypertension. Those with a diet of high salt intake were found to be more likely to have high blood pressure than those who had less salt. In addition, blood pressure increased as salt intake rose over time. The study was […]

Auto-inflation to treat glue ear

Wednesday, July 29th, 2015

According to a new study, a treatment method called auto-inflation could be used to treat otitis media with effusion, a common ear condition also known as glue ear. Auto-inflation uses a nasal balloon to reduce the presence of the ear condition. Glue ear is tied to childhood hearing loss and causes fluid to build up […]

Combination of two medications may help treat breast cancer

Tuesday, July 28th, 2015

According to two new UK studies, a combination of bisphosphonates and aromatase inhibitors (AI) may help raise early breast cancer survival rates for postmenopausal patients. The two could be used together for added benefits and fewer side effects. AIs counteract estrogen stimulation, which is done by women to counteract menopausal symptoms. Previous research has seen […]

Older patients may not benefit from arthroscopic knee surgery

Monday, July 27th, 2015

According to a Danish study, a common knee surgery called arthroscopic surgery may not be beneficial to middle-aged or order patients, and may even harm them. The study was led by JB Thorlund, a professor of sports medicine and orthopedic surgery at the University of Southern Denmark, who said, “The small inconsequential benefit seen from […]

Testosterone therapy may cause VTE

Sunday, July 26th, 2015

According to a new study, testosterone therapy may not be linked to venous thromboembolism (VTE), a blood clot disorder that has been linked to the treatment in the past. The study found that testosterone therapy does not raise the risk of VTE, despite past concerns. The lead author was Jacques Baillargeon, of the University of […]

FDA approves alirocumab to treat high cholesterol

Saturday, July 25th, 2015

The US Food and Drug Administration (FDA) has approved a drug called alirocumab (brand name Praluent) from Sanofi-Aventis to treat high levels of cholesterol. This is the first injectable cholesterol medication in its class. John Jenkins, director of the Office of New Drugs at the Center for Drug Evaluation and Research, FDA, said, “Praluent provides […]

FDA approves new skin cancer drug

Friday, July 24th, 2015

The US Food and Drug Administration (FDA) has approved a new medication called sonidegib (brand name Odomzo) from Novartis to treat a common skin cancer type called locally-advanced basal cell carcinoma. Locally-advanced basal cell carcinoma is a form of skin cancer that reappears after surgery or radiation treatment. The new drug has also been approved […]

Extra radiation may reduce recurrence risk of breast cancer

Thursday, July 23rd, 2015

According to a new Canadian study, additional radiation in surround areas of the breast may reduce the recurrence risk of breast cancer for some patients. The study was led by Timothy Whelan, of the Juravinski Cancer Centre in Ontario, who said, “Additional radiation to the surrounding lymph nodes reduced the risk of subsequent recurrence of […]

Glitazone may prevent Parkinson’s disease

Wednesday, July 22nd, 2015

Glitazone, a diabetes medication, may help prevent Parkinson’ disease (PD) according to a new study by the London School of Hygiene & Tropical Medicine (LSHTM). The study found that diabetes patients taking the medication consistently had a much lower risk of developing PD. Senior author Ian Douglas said, “We often hear about negative side effects […]

« Previous Entries